...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: $60m PP Question

Hi Bear/SF, thanks for the warm welcome, however, I've been lurking around for years (I just forgot my prior login details so had to create a new account). I  have my Zenith shares from the RVX split.

I did too see the 10M PP soon but no matter how I look at the math, could not come up with the $60M mentioned on the other board.

Also, wondering if the 10M share issue will be announced at JPM (pure speculation)

Share
New Message
Please login to post a reply